Sildenafil Inhibits Phosphodiesterase Type 5 in Human Clitoral Corpus Cavernosum Smooth Muscle
Data up to Jan 2025
Total Citations Per Year
Abstract
References (17)
The determination of enzyme inhibitor constants
1953 • 4,050 citations
Oral Sildenafil in the Treatment of Erectile Dysfunction
1998 • 2,097 citations
Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms
1995 • 1,780 citations
Physiology of penile erection
1995 • 1,113 citations
Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction.
1996 • 1,070 citations
Nitric Oxide in the Penis: Physiology and Pathology
1997 • 352 citations
Purification and characterization of a cyclic GMP-stimulated cyclic nucleotide phosphodiesterase from bovine tissues.
1982 • 317 citations
Oxygen tension regulates the nitric oxide pathway. Physiological role in penile erection.
1993 • 294 citations
Investigative Urology: PGE sub 1 Suppresses the Induction of Collagen Synthesis by Transforming Growth Factor-beta sub 1 in Human Corpus Cavernosum Smooth Muscle
1995 • 251 citations
Vasculogenic female sexual dysfunction: The hemodynamic basis for vaginal engorgement insufficiency and clitoral erectile insufficiency
1997 • 237 citations
Cyclic Nucleotide Phosphodiesterases and Vascular Smooth Muscle
1996 • 205 citations
Sildenafil, a novel inhibitor of phosphodiesterase type 5 in human corpus cavernosum smooth muscle cells
1998 • 198 citations
Immunohistochemical Description of Nitric Oxide Synthase Isoforms in Human Clitoris
1997 • 163 citations
ORAL AND TOPICAL TREATMENT OF ERECTILE DYSFUNCTION
1995 • 59 citations
cGMP signal termination
1996 • 57 citations
Immunohistochemical study of the corpora cavernosa of the human clitoris.
1996 • 49 citations
The female corpus spongiosum revisited
1995 • 38 citations